Giulia Torriani
Overview
Explore the profile of Giulia Torriani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Essaidi-Laziosi M, Perez-Rodriguez F, Alvarez C, Sattonnet-Roche P, Torriani G, Bekliz M, et al.
Virus Res
. 2024 Feb;
339:199255.
PMID: 38389324
SARS-CoV-2's genetic plasticity has led to several variants of concern (VOCs). Here we studied replicative capacity for seven SARS-CoV-2 isolates (B.1, Alpha, Beta, Gamma, Delta, Zeta, and Omicron BA.1) in...
2.
Essaidi-Laziosi M, Alvarez C, Puhach O, Sattonnet-Roche P, Torriani G, Tapparel C, et al.
Emerg Microbes Infect
. 2021 Dec;
11(1):412-423.
PMID: 34931581
Although frequently reported since the beginning of the pandemic, questions remain regarding the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interaction with circulating respiratory viruses in coinfected patients....
3.
Mayor J, Torriani G, Engler O, Rothenberger S
Viruses
. 2021 Apr;
13(4).
PMID: 33923413
Hemorrhagic fever viruses, among them orthohantaviruses, arenaviruses and filoviruses, are responsible for some of the most severe human diseases and represent a serious challenge for public health. The current limited...
4.
Berger A, Nsoga M, Perez-Rodriguez F, Abi Aad Y, Sattonnet-Roche P, Gayet-Ageron A, et al.
PLoS One
. 2021 Mar;
16(3):e0248921.
PMID: 33788882
Objectives: Determine the diagnostic accuracy of two antigen-detecting rapid diagnostic tests (Ag-RDT) for SARS-CoV-2 at the point of care and define individuals' characteristics providing best performance. Methods: We performed a...
5.
Vetter P, LHuillier A, Montalbano M, Pigny F, Eckerle I, Torriani G, et al.
Emerg Infect Dis
. 2021 Jan;
27(2):658-660.
PMID: 33496646
We report 3 cases of Puumala virus infection in a family in Switzerland in January 2019. Clinical manifestations of the infection ranged from mild influenza-like illness to fatal disease. This...
6.
Gasbarri M, Vkovski P, Torriani G, Thiel V, Stellacci F, Tapparel C, et al.
Microorganisms
. 2020 Dec;
8(12).
PMID: 33265927
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several...
7.
Grazioli S, Tavaglione F, Torriani G, Wagner N, Rohr M, LHuillier A, et al.
J Pediatric Infect Dis Soc
. 2020 Nov;
10(6):706-713.
PMID: 33180935
Background: Recently, cases of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) have been reported worldwide. Negative polymerase chain reaction (RT-PCR) testing associated with positive serology...
8.
Vetter P, Eberhardt C, Meyer B, Martinez Murillo P, Torriani G, Pigny F, et al.
mSphere
. 2020 Nov;
5(6).
PMID: 33177214
Viral shedding patterns and their correlations with immune responses are still poorly characterized in mild coronavirus (CoV) disease 2019 (COVID-19). We monitored shedding of viral RNA and infectious virus and...
9.
Meyer B, Reimerink J, Torriani G, Brouwer F, Godeke G, Yerly S, et al.
Emerg Microbes Infect
. 2020 Oct;
9(1):2394-2403.
PMID: 33043818
To understand SARS-CoV-2 immunity after natural infection or vaccination, functional assays such as virus neutralising assays are needed. So far, assays to detect SARS-CoV-2 neutralising antibodies rely on cell-culture based...
10.
Muench P, Jochum S, Wenderoth V, Ofenloch-Haehnle B, Hombach M, Strobl M, et al.
J Clin Microbiol
. 2020 Aug;
58(10).
PMID: 32747400
The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was developed to provide accurate, reliable detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluated sensitivity, specificity, cross-reactivity, and agreement...